This is not the most recent version of the article. View current version (28 OCT 2015)

Intervention Review

You have free access to this content

Sulthiame add-on therapy for epilepsy

  1. Philip Milburn-McNulty1,*,
  2. Graham Powell1,
  3. Graeme J Sills2,
  4. Anthony G Marson2

Editorial Group: Cochrane Epilepsy Group

Published Online: 28 MAR 2013

Assessed as up-to-date: 19 FEB 2013

DOI: 10.1002/14651858.CD009472.pub2


How to Cite

Milburn-McNulty P, Powell G, Sills GJ, Marson AG. Sulthiame add-on therapy for epilepsy. Cochrane Database of Systematic Reviews 2013, Issue 3. Art. No.: CD009472. DOI: 10.1002/14651858.CD009472.pub2.

Author Information

  1. 1

    The Walton Centre for Neurology & Neurosurgery NHS Trust, Liverpool, UK

  2. 2

    Institute of Translational Medicine, University of Liverpool, Department of Molecular and Clinical Pharmacology, Liverpool, Merseyside, UK

*Philip Milburn-McNulty, The Walton Centre for Neurology & Neurosurgery NHS Trust, Lower Lane, Fazakerley, Liverpool, L9 7LJ, UK. philmilburnmcnulty@gmail.com.

Publication History

  1. Publication Status: New
  2. Published Online: 28 MAR 2013

SEARCH

This is not the most recent version of the article. View current version (28 OCT 2015)

[Analysis 1.1]
Analysis 1.1. Comparison 1 Sulthiame add-on versus placebo, Outcome 1 Complete cessation of seizures.
[Analysis 1.2]
Analysis 1.2. Comparison 1 Sulthiame add-on versus placebo, Outcome 2 Adverse effects - total.
[Analysis 1.3]
Analysis 1.3. Comparison 1 Sulthiame add-on versus placebo, Outcome 3 Adverse effects - somnolence.